Lumida
/ARDX
⌘K
Ardelyx Inc

Ardelyx Inc

ARDX
$3.81USD-0.26%-0.01 today

MARKET CAP

961.9M

P/E (TTM)

FWD P/E

DAY RANGE

$4 – $4

52W RANGE

$4
$8

AI Summary

Stalk
TrimMedium

ARDX is in a pronounced Stage 4 downtrend, trading below all major EMAs with a clear lower-highs/lower-lows sequence. Medium-term bias is bearish, favoring selling rallies into the EMA9/20 resistance zone rather than initiating new positions at extreme lows. Short-term conditions remain unfavorable for selling into support near its 52-week low, so patience is warranted for bounce rejections around $4.06–4.21. Execution should focus on disciplined rejection at resistance levels.

  • Q2 2026 product revenue $118.1M (+31% YoY), IBSRELA $86.2M (+33% YoY).
  • Cash & equivalents of $281.8M support R&D and operations.
  • ROE of -39% highlights weak profitability and capital inefficiency.
Full analysis →
STATEMENT·Income statement
USD · GAAP
METRICFY 2021FY 2022FY 2023FY 2024FY 2025TREND
Sales, Adj.$10.1M$52.2M$124.5M$333.6M$407.3M
YoY %+33.4%+416.6%+138.6%+168.1%+22.1%
P / Sales11.4x8.2x10.7x3.6x3.4x
EV / Sales10.8x8.1x11.5x4.2x4.1x
Gross Profit, Adj.$9.1M$48.0M$106.7M$283.1M$367.8M
YoY %+22.5%+428.1%+122.0%+165.4%+29.9%
Margin %90.1%92.1%85.7%84.8%90.3%
EV / Gross Profit12.0x8.8x13.5x4.9x4.5x
EBITDA, Adj.$-148.5M$-62.6M$-62.0M$-25.9M$-37.9M
YoY %-68.2%+57.8%+1.0%+58.2%-46.5%
Margin %-1470.3%-120.0%-49.8%-7.8%-9.3%
EV / EBITDA-0.7x-6.7x-23.2x-53.7x-44.1x
EBIT$-154.3M$-63.8M$-63.3M$-27.9M$-41.0M
YoY %-70.0%+58.7%+0.8%+55.8%-46.6%
Margin %-1528.6%-122.2%-50.8%-8.4%-10.1%
EV / EBIT-0.7x-6.6x-22.7x-49.7x-40.8x
Net Income$-158.2M$-67.2M$-66.1M$-39.1M$-61.6M
YoY %-67.7%+57.5%+1.7%+40.8%-57.4%
Net Margin-1566.5%-128.9%-53.1%-11.7%-15.1%
EPS (GAAP)-$1.52-$0.42-$0.30-$0.17-$0.26
YoY %-44.8%+72.4%+28.6%+43.3%-52.9%